If a patient needs more tests along the breast care pathway, there are solutions designed to give them the best possible patient experience. For example, if a diagnostic exam is needed following an inconclusive mammogram – often a troubling time for a patient – a clinician can use contrast-enhanced spectral mammography to highlight areas of unusual blood flow to help localize a known or suspected lesion. It can be done the same day, in the same room, in less than seven minutes with images immediately available for a radiologist to review to provide immediate answers for a patient.
And if an interventional procedure is needed, there are biopsy devices highly focused on minimizing patient distress. A biopsy can be an invasive and uncomfortable procedure but is necessary for diagnosing breast cancer – which means any effort to ease patient anxiety can help. For example, a newly designed side approach for the procedure reduces needle visibility to the patient, and workflow improvements cut the exam time to under 15 minutes.
Ad Statistics
Times Displayed: 1581
Times Visited: 8 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
To continue advancing breast health technology, the patient must be at the center of every design. The revolution in breast care is not aspirational – it’s transformational, and it’s happening now. The industry is dedicated to enabling clinicians to do their jobs faster, easier and with improved clinical outcomes. And most importantly, we are dedicated to making a difference in patients’ lives as we continue the fight against breast cancer.
About the author: Agnes Berzsenyi is the president and CEO of GE Healthcare Women’s HealthBack to HCB News
